STOCK TITAN

GTCR lists 11.2% stake in Sotera Health (NYSE: SHC) via joint disclosure

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

GTCR Reporting Persons filed Amendment No. 6 to a Schedule 13G/A reporting shared voting power over 31,838,253 shares of Sotera Health Co. That amount represents approximately 11.2% of the 284,392,079 shares outstanding as of February 17, 2026, per the issuer's prospectus supplement.

The filing states the GTCR investors and the Warburg Pincus investors are party to a Stockholders Agreement covering governance and voting arrangements; the filing also notes that GTCR expressly disclaims beneficial ownership of shares owned of record by the Warburg Pincus investors. The filing is a joint disclosure by several GTCR entities, with signatures by Jeffrey Wright.

Positive

  • None.

Negative

  • None.

Insights

Joint filing clarifies group voting ties and disclaimers.

The Schedule 13G/A amendment records 31,838,253 shares tied to GTCR and Warburg Pincus under a Stockholders Agreement. The filing describes agreed voting arrangements for director-related matters and quantifies the combined position as 11.2% of outstanding shares as of February 17, 2026.

The filing also contains explicit legal language: each GTCR Reporting Person "expressly disclaims beneficial ownership" of shares held of record by the Warburg Pincus investors. Subsequent disclosures by the Warburg Pincus entities are the appropriate source for their precise holdings.

Disclosure signals a coordinated block but not direct dispositive control.

The filing lists shared voting power of 31,838,253 shares and specifies GTCR-owned record shares totaling 12,735,301 across GTCR entities, with the Warburg Pincus sponsors reported at 19,102,952 in a separate Form 4.

This is a static ownership disclosure for market participants; cash‑flow treatment and any planned transactions are not described. Future filings by the group members may clarify voting coordination or transfers.






03/06/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: (1) As more fully described in Item 4 of this Amendment No. 6 to Schedule 13G, the GTCR Investors (as defined in Item 2) are party to a Stockholders Agreement with the Warburg Pincus Investors (as defined in Item 4) and certain other holders of Common Stock of the Issuer. The GTCR Investors, together with the Warburg Pincus Investors, hold an aggregate total of 31,838,253 shares of Common Stock of the Issuer (approximately 11.2% of the outstanding shares of Common Stock of the Issuer), of which 19,102,952 shares of Common Stock are publicly reported as being owned by the Warburg Pincus Investors in such entities' Form 4, filed with the U.S. Securities and Exchange Commission ("Commission") on March 10, 2026. Although the GTCR Reporting Persons (as defined in Item 2) may be deemed to beneficially own the Common Stock held of record by the Warburg Pincus Investors as a result of the Stockholders Agreement, each GTCR Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act")) with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such GTCR Reporting Person. The percentages used herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,392,079 shares of Common Stock outstanding as of February 17, 2026 as reported on the Issuer's final prospectus supplement, filed pursuant to Rule 424(b)(7) on March 5, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) As more fully described in Item 4 of this Amendment No. 6 to Schedule 13G, the GTCR Investors are party to a Stockholders Agreement with the Warburg Pincus Investors and certain other holders of Common Stock of the Issuer. The GTCR Investors, together with the Warburg Pincus Investors, hold an aggregate total of 31,838,253 shares of Common Stock of the Issuer (approximately 11.2% of the outstanding shares of Common Stock of the Issuer), of which 19,102,952 shares of Common Stock are publicly reported as being owned by the Warburg Pincus Investors in such entities' Form 4, filed with the Commission on March 10, 2026. Although the GTCR Reporting Persons may be deemed to beneficially own the Common Stock held of record by the Warburg Pincus Investors as a result of the Stockholders Agreement, each GTCR Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such GTCR Reporting Person. The percentages used herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,392,079 shares of Common Stock outstanding as of February 17, 2026 as reported on the Issuer's final prospectus supplement, filed pursuant to Rule 424(b)(7) on March 5, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) As more fully described in Item 4 of this Amendment No. 6 to Schedule 13G, the GTCR Investors are party to a Stockholders Agreement with the Warburg Pincus Investors and certain other holders of Common Stock of the Issuer. The GTCR Investors, together with the Warburg Pincus Investors, hold an aggregate total of 31,838,253 shares of Common Stock of the Issuer (approximately 11.2% of the outstanding shares of Common Stock of the Issuer), of which 19,102,952 shares of Common Stock are publicly reported as being owned by the Warburg Pincus Investors in such entities' Form 4, filed with the Commission on March 10, 2026. Although the GTCR Reporting Persons may be deemed to beneficially own the Common Stock held of record by the Warburg Pincus Investors as a result of the Stockholders Agreement, each GTCR Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such GTCR Reporting Person. The percentages used herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,392,079 shares of Common Stock outstanding as of February 17, 2026 as reported on the Issuer's final prospectus supplement, filed pursuant to Rule 424(b)(7) on March 5, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) As more fully described in Item 4 of this Amendment No. 6 to Schedule 13G, the GTCR Investors are party to a Stockholders Agreement with the Warburg Pincus Investors and certain other holders of Common Stock of the Issuer. The GTCR Investors, together with the Warburg Pincus Investors, hold an aggregate total of 31,838,253 shares of Common Stock of the Issuer (approximately 11.2% of the outstanding shares of Common Stock of the Issuer), of which 19,102,952 shares of Common Stock are publicly reported as being owned by the Warburg Pincus Investors in such entities' Form 4, filed with the Commission on March 10, 2026. Although the GTCR Reporting Persons may be deemed to beneficially own the Common Stock held of record by the Warburg Pincus Investors as a result of the Stockholders Agreement, each GTCR Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such GTCR Reporting Person. The percentages used herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,392,079 shares of Common Stock outstanding as of February 17, 2026 as reported on the Issuer's final prospectus supplement, filed pursuant to Rule 424(b)(7) on March 5, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) As more fully described in Item 4 of this Amendment No. 6 to Schedule 13G, the GTCR Investors are party to a Stockholders Agreement with the Warburg Pincus Investors and certain other holders of Common Stock of the Issuer. The GTCR Investors, together with the Warburg Pincus Investors, hold an aggregate total of 31,838,253 shares of Common Stock of the Issuer (approximately 11.2% of the outstanding shares of Common Stock of the Issuer), of which 19,102,952 shares of Common Stock are publicly reported as being owned by the Warburg Pincus Investors in such entities' Form 4, filed with the Commission on March 10, 2026. Although the GTCR Reporting Persons may be deemed to beneficially own the Common Stock held of record by the Warburg Pincus Investors as a result of the Stockholders Agreement, each GTCR Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such GTCR Reporting Person. The percentages used herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,392,079 shares of Common Stock outstanding as of February 17, 2026 as reported on the Issuer's final prospectus supplement, filed pursuant to Rule 424(b)(7) on March 5, 2026.


SCHEDULE 13G



GTCR INVESTMENT XI LLC
Signature:/s/ Jeffrey Wright
Name/Title:Jeffrey Wright, Chief Legal Officer
Date:03/10/2026
GTCR FUND XI/A LP
Signature:/s/ Jeffrey Wright
Name/Title:Jeffrey Wright, Chief Legal Officer of GTCR Invest. XI LLC, the general partner of GTCR Partners XI/A&C LP, the general partner of GTCR FUND XI/A LP
Date:03/10/2026
GTCR FUND XI/C LP
Signature:/s/ Jeffrey Wright
Name/Title:Jeffrey Wright, Chief Legal Officer of GTCR Invest. XI LLC, the general partner of GTCR Partners XI/A&C LP, the general partner of GTCR FUND XI/C LP
Date:03/10/2026
GTCR CO-INVEST XI LP
Signature:/s/ Jeffrey Wright
Name/Title:Jeffrey Wright, Chief Legal Officer of GTCR Investment XI LLC, the general partner of GTCR CO-INVEST XI LP
Date:03/10/2026
GTCR PARTNERS XI/A&C LP
Signature:/s/ Jeffrey Wright
Name/Title:Jeffrey Wright, Chief Legal Officer of GTCR Investment XI LLC, the general partner of GTCR PARTNERS XI/A&C LP
Date:03/10/2026

Comments accompanying signature: Exhibit 99.1 Agreement of Joint Filing as required by Rule 13d-1(k)(1) under the Act.* * Incorporated herein by reference to the Agreement of Joint Filing by GTCR Investment XI LLC, GTCR Fund XI/A LP, GTCR Fund XI/C LP, GTCR Co-Invest XI LP and GTCR Partners XI/A&C LP dated as of February 11, 2022, which was previously filed with the Commission as Exhibit A to Amendment No. 1 to Schedule 13G filed by GTCR Investment XI LLC, GTCR Fund XI/A LP, GTCR Fund XI/C LP, GTCR Co-Invest XI LP and GTCR Partners XI/A&C LP on February 11, 2022 with respect to the shares of common stock of Sotera Health Co.

FAQ

What stake does GTCR report in Sotera Health (SHC)?

GTCR reports shared voting power over 31,838,253 shares, equal to about 11.2% of the class based on February 17, 2026. The figure is the combined total held by GTCR and Warburg Pincus under a Stockholders Agreement.

Does GTCR claim direct beneficial ownership of all 31,838,253 shares?

No. GTCR disclaims beneficial ownership of shares held of record by the Warburg Pincus investors and limits its claimed ownership to shares each GTCR entity owns of record, per the filing language.

How was the outstanding share base determined in the filing?

The percentage uses 284,392,079 shares outstanding as of February 17, 2026, per the issuer's final prospectus supplement filed under Rule 424(b)(7) on March 5, 2026.

What governance arrangements are referenced in the filing?

The filing references a Stockholders Agreement entered on November 19, 2020 that sets voting protocols for director elections and includes transfer restrictions and indemnification terms among the GTCR and Warburg Pincus investors.

Will this filing tell me whether GTCR plans to sell or buy more SHC shares?

No. The amendment is an ownership disclosure describing current shared voting power and the Stockholders Agreement; it does not state any planned purchases, sales, or cash‑flow treatment.
Sotera Health Co

NASDAQ:SHC

View SHC Stock Overview

SHC Rankings

SHC Latest News

SHC Latest SEC Filings

SHC Stock Data

3.77B
245.76M
Diagnostics & Research
Services-misc Health & Allied Services, Nec
Link
United States
BROADVIEW HEIGHTS